Miguel de los Rios

Miguel de los Rios, PhD is trained in protein engineering and polymer biophysical chemistry and is the founder and Chief Executive Officer of both Endeavor Biomedicines and RIFT Biotherapeutics. He’s also Vice President of Research and Development at Sevion Therapeutics, a publicly traded therapeutics company with a focus in oncology and autoimmune disorders. Previously, Miguel founded Chimeros, Inc., a venture-backed biologics therapeutic company. At Chimeros, he served as both the CEO as well as the CSO from 2003-2011 and was the inventor of the company’s core technologies.